title: Del-1 overexpression in endothelial cells increases vascular density in tissue-engineered implants containing endothelial cells and adipose-derived mesenchymal stromal cells.
abstract: We used a combination of strategies to stimulate the vascularization of tissue-engineered constructs in vivo including a modular approach to build larger tissues from individual building blocks ("modules") mixed together. Each building block included vascular cells by design; modules were submillimeter-sized collagen gels with an outer layer of endothelial cells (ECs), and with embedded adipose-derived mesenchymal stromal cells (adMSCs) to support EC survival and blood vessel maturation in vivo. We transduced the ECs that coat the modules with a lentiviral construct to overexpress the angiogenic extracellular matrix (ECM) protein Developmental endothelial locus-1 (Del-1). Upon injection of modules in a subcutaneous SCID/Bg mouse model, there was an increase in the number of blood vessels for implants with ECs transduced to overexpress Del-1 compared with control implants (with enhanced green fluorescent protein [eGFP]-transduced ECs) over the 21-day duration of the study. The greatest difference between Del-1 and eGFP implants and the highest number of blood vessels were observed 7 days after transplantation. The day-7 Del-1 implants also had increased SMA+ staining compared with control, suggesting increased blood vessel maturation through recruitment of SMA+ smooth muscle cells or pericytes to stabilize the newly formed blood vessels. Perfusion studies (microcomputed tomography, ultrasound imaging, and systemic injection of fluorescent UEA-1 or dextran) showed that some of the newly formed blood vessels (both donor derived and host derived, in both Del-1 and eGFP implants) were perfused and connected to the host vasculature as early as 7 days after transplantation, and at later time points as well. Nevertheless, perfusion of the implants was limited in some cases, suggesting that further improvements are necessary to normalize the vasculature at the implant site.
authors.affiliation: 1 Department of Chemical Engineering and Applied Chemistry, University of Toronto , Toronto, Canada .
authors.forename: Ema C
authors.initials: EC
authors.lastname: Ciucurel
authors.forename: Michael V
authors.initials: MV
authors.lastname: Sefton
mesh_terms: D000273:Adipose Tissue / Q000166:cytology*; D000818:Animals; D017209:Apoptosis; D001808:Blood Vessels / Q000502:physiology*; D002135:Calcium-Binding Proteins; D002352:Carrier Proteins / Q000378:metabolism*; D015815:Cell Adhesion Molecules; D002454:Cell Differentiation; D049109:Cell Proliferation; D018920:Coculture Techniques; D061307:Human Umbilical Vein Endothelial Cells / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D020007:Implants, Experimental; D036341:Intercellular Signaling Peptides and Proteins; D037102:Lectins / Q000378:metabolism; D007962:Leukocytes / Q000166:cytology; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism; D051379:Mice; D045423:Microbubbles; D010477:Perfusion; D020286:Pericytes / Q000166:cytology; D019919:Prosthesis Implantation; D012235:Rhodamines / Q000378:metabolism; D013194:Staining and Labeling; D023822:Tissue Engineering / Q000379:methods*; D014465:Ultrasonics; D055114:X-Ray Microtomography; D014966:Xanthenes / Q000378:metabolism
chemical_list: D002135:Calcium-Binding Proteins; D002352:Carrier Proteins; D015815:Cell Adhesion Molecules; C491706:Edil3 protein, mouse; D036341:Intercellular Signaling Peptides and Proteins; D037102:Lectins; D012235:Rhodamines; D014966:Xanthenes; C034657:Texas red